Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Aug 19, 2014
Insider Transaction Report
Form 4
Peabody Robert
Chief Financial Officer
Transactions
- Other
Series A Common Stock
2014-08-15+41→ 41 total
Holdings
- 125,000
Option to Purchase Series B Common Stock
Exercise: $2.34Exp: 2020-06-23→ Series B Common Stock (125,000 underlying)
Footnotes (3)
- [F1]Shares received from Geron Corporation as part of distribution to holders of Geron Common Stock.
- [F2]Options pertain to the purchase of Series B common stock. The Series B common stock may be converted into Series A common stock by the company upon the occurrence of certain events, and the options will become exercisable for the purchase of Series A common stock when outstanding Series B common stock is converted into Series A common stock.
- [F3]1/48th of the number of options will vest and become exercisable at the end of each full month of employment after the date of grant on June 24, 2013.